Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2018/02/01
-
Journal
-
Indian UGC (journal)
-
Refrences188
-
Citations228
-
Abdul-Rehman Phull ORCID (unauthenticated)
-
Bakht Nasir
-
Ihsan ul Haq
-
Song Ja Kim
Cite
Phull, Abdul-Rehman, et al. “Oxidative Stress, Consequences and ROS Mediated Cellular Signaling in Rheumatoid Arthritis”. Chemico-Biological Interactions, vol. 281, 2018, pp. 121-36, https://doi.org/10.1016/j.cbi.2017.12.024.
Phull, A.-R., Nasir, B., Haq, I. ul, & Kim, S. J. (2018). Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chemico-Biological Interactions, 281, 121-136. https://doi.org/10.1016/j.cbi.2017.12.024
Phull, Abdul-Rehman, Bakht Nasir, Ihsan ul Haq, and Song Ja Kim. “Oxidative Stress, Consequences and ROS Mediated Cellular Signaling in Rheumatoid Arthritis”. Chemico-Biological Interactions 281 (2018): 121-36. https://doi.org/10.1016/j.cbi.2017.12.024.
1.
Phull AR, Nasir B, Haq I ul, Kim SJ. Oxidative stress, consequences and ROS mediated cellular signaling in rheumatoid arthritis. Chemico-Biological Interactions. 2018;281:121-36.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Science
Biology (General)
You May Also Like
- Photodynamic therapy – mechanisms, photosensitizers and combinations
- Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
- Chlorogenic acid (CGA): A pharmacological review and call for further research
- Redox signaling and the MAP kinase pathways
- Biological effects of a nano red elemental selenium
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Endogenous non-enzymatic antioxidants in the human body | Advances in Medical Sciences |
| 306 | 2018 |
| Reduction of non-enzymatic antioxidants in plasma during ECMO-treatment in ARDS by influence A H1N1 | Journal of Critical Care |
| 6 | 2018 |
Applications of Chondrocyte-Based Cartilage Engineering: An Overview | BioMed Research International |
| 74 | 2017 |
| Applications of computational chemistry to the study of the antiradical activity of carotenoids: A review | Food Chemistry |
| 34 | 2017 |
| α-Lipoic acid ameliorates oral mucositis and oxidative stress induced by methotrexate in rats. Histological and immunohistochemical study | Life Sciences |
| 9 | 2017 |
Refrences Analysis
The category
Science: Biology (General) 59
is the most frequently represented among the references in this article. It primarily includes studies from Cell and Molecular Cell. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Anti‐rheumatic potential vis‐à‐vis aconitine and hypaconitine content analysis in different Aconitum spp. from Sikkim Himalayas (India) | Chemistry & Biodiversity |
| 2024 | |
Association between Mediterranean‐dietary approaches to stop hypertension intervention for neurodegenerative delay diet and biomarkers of oxidative stress, metabolic factors, disease severity, and odds of disease in rheumatoid arthritis patients | Food Science & Nutrition |
| 2024 | |
| Advances in local drug delivery technologies for improved rheumatoid arthritis therapy | Advanced Drug Delivery Reviews |
| 2024 | |
| Physiological response mechanisms of hybrid Pelteobagrus fulvidraco in response to different dissolved oxygen | Aquaculture |
| 2024 | |
| Isoliquiritigenin inhibits apoptosis and ameliorates oxidative stress in rheumatoid arthritis chondrocytes through the Nrf2/HO-1-mediated pathway | Biomedicine & Pharmacotherapy |
| 2024 |
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 62
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Resveratrol Alleviates Rheumatoid Arthritis via Reducing ROS and Inflammation, Inhibiting MAPK Signaling Pathways, and Suppressing Angiogenesis and was published in 2018. The most recent citation comes from a 2024 study titled Advances in local drug delivery technologies for improved rheumatoid arthritis therapy. This article reached its peak citation in 2022, with 58 citations. It has been cited in 150 different journals, 28% of which are open access. Among related journals, the Antioxidants cited this research the most, with 10 citations. The chart below illustrates the annual citation trends for this article.